Value Bridge — RIVERVIEW MEDICAL CENTER
Current $20M → Target $28M (+$8.1M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$20.3M
Current EBITDA
$28.4M
Target EBITDA
+$8.1M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$1.8M
Payer Mix Optimization
$4.4M
Cost to Collect Reduction
$1.5M
Clean Claim Improvement
$1.1M
Volume & Rate Growth
$7.3M
What This Means
The 7-lever model projects a 40% EBITDA uplift from $20M to $28M. The highest-impact lever is Volume & Rate Growth at $2.9M probability-weighted.
IC talking point: "We see $8M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $89M in equity value creation."